Cellular energy metabolism detection further demonstrated that IMP2 silencing weakened the cells’ glycolytic capacity, whereas ZFAS1 could reverse the effect of IMP2 silencing on the reduced glycolysis levels in these two types of CRC cells (Fig. 6g, h). Here, ZFAS1 is linked to colorectal carcinoma.